INDICATIONS AND USAGE Desonide lotion is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

ADVERSE REACTIONS In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide was approximately 8%.

These were: stinging and burning approximately 3%, irritation, contact dermatitis, condition worsened, peeling of skin, itching, intense transient erythema, and dryness/scaliness, each less than 2%.

The following additional local adverse reactions have been reported infrequently with other topical corticosteroids, and they may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids.

These reactions are listed in an approximate decreasing order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, secondary infection, skin atrophy, striae, and miliaria.

To report SUSPECTED ADVERSE REACTIONS, contact Alembic Pharmaceuticals, Inc.

at 1-866-210-9797 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.